4-chlorocatechol 4,5-dichlorocatechol 3,4,5-trichlorocatechol Tetrachlorocatechol 4,5-dichloroguaiacol 4,5,6-trichloroguaiacol 3,4,5-trichloroguaiacol Tetrachloroguaiacol 4,5-dichloroveratrole 3,4,5-trichloroveratrole Tetrachloroveratrole 4-chloroguaiacol Trichlorosyringol 5,6-dichlorovanillin 6-chlorovanillin 4,6-dichloroguaiacol 3,5-dichlorocatechol 3,4,6-trichlorocatechol 3,4-dichlorocatechol Dehydroabietic Abietic Neoabietic Isopimaric Levopimaric Palustric Sandaracopimaric Chlorodehydroabietic Dichlorodehydroabietic o-Methylpodocarpic Pimaric Dihydroisopimaric 8(14)-abietenic 8-abietenic 7-oxodehydroabietic acid 9,10-dichlorostearic Acid Racemic Pazufloxacin Mesylate Pitavastatin calcium Pirarubicin Hydrochloride 1,1-Dibromoacetone 1,1,1-Tribromoacetone 1,1,3-Tribromoacetone 1,1-Dibromo-3-chloroacetone 1,1-Dibromo-3,3-dichloroacetone 1,3-Dibromo-1,3-dichloroacetone 1,1,3-Tribromo-3-chloroacetone 1,1,3,3-Tetrachloroacetone 1,1,1,3-Tetrachloroacetone Chloronitromethane Dichloronitromethane Bromodichloronitromethane
|
|
No. |
Products |
CAS No. |
Specifications
|
Price
|
优惠价 |
预计发货期 |
CHI-8488.15-20-025IO |
1,1,2,5,5-Pentamethyldecaline (trans) |
59935-26-1 |
|
CHI-0787.30-100-IO |
18(H)-Olean-12(13)-ene |
471-68-1 |
|
CHI-0787.30-2MG |
18(H)-Olean-12(13)-ene |
471-68-1 |
|
CHI-0786.30-100-IO |
Urs-12(13)-ene |
464-97-1 |
|
CHI-0786.30-10MG |
Urs-12(13)-ene |
464-97-1 |
|
CHI-0788.2-KIT |
Ursene and oleanene Kit, solutions |
|
|
CHI-2646.30-10UG |
Gammacerane |
559-65-9 |
1×ca. 10μg |
20642 |
请询价 |
3-4周 |
|
CHI-9953.30-10UG |
Bicadinane W |
130466-40-9 |
1×ca. 10μg |
18444 |
请询价 |
3-4周 |
|
CHI-9952.30-50-IO |
Bicadinane T |
10191-10-0 |
|
CHI-9951.30-10UG |
Bicadinane R |
N/A |
1×ca. 10μg |
18444 |
请询价 |
3-4周 |
|
CHI-9954.31-10UG |
Bicadinane T1 |
N/A |
1×ca. 10μg |
18444 |
请询价 |
3-4周 |
|
CHI-9955.4-KIT |
Bicadinane Kit (incl. W, T, R, T1) |
|
|
CHI-0619.30-100-IO |
Friedelane |
559-73-9 |
|
CHI-0620.30-100-IO |
Onocerane I (8(H),14α(H)) |
56297-92-8 |
|
CHI-0621.30-100-IO |
Onocerane II (8(H),14(H)) |
13384-96-8 |
|
|
|